Local Manufacturing Moving Forward

Uganda's Kampala Pharmaceutical Industries (KPI) has announced that it now manufactures the anti-hypertensive drug Cardipac (amlodipine). The firm also states that the drug's retail price will be 50% lower than the imported equivalent. Uganda is gradually becoming a more attractive target for FDI in east Africa and arguably, the performance of its domestic pharmaceutical manufacturing industry is critical to reducing import reliance.

To read the full article, please choose one of the following options: